Case report: Reactivation of mucosal and cutaneous leishmaniasis in a renal transplanted patient

24Citations
Citations of this article
48Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Mucosal leishmaniasis (ML) is a chronic form of tegumentary leishmaniasis, which causes destructive lesions of nasal, pharyngeal, and laryngeal mucosa. We describe a case of leishmaniasis reactivation with simultaneous cutaneous and mucosal forms in a renal transplanted patient with no history of prior leishmaniasis. Reactivation after renal transplantation was not reported in Brazil. A 67-year-old woman receiving prednisone 20 mg/day, tacrolimus 1 mg/day, and mycophenolic acid 360 mg/day presented with nose edema with erythema and cutaneous lesions. Amastigotes were identified on biopsies and the polymerase chain reaction confirmed Leishmania (Viannia) braziliensis. The patient was treated with liposomal amphotericin B but died 3 weeks after as a result of bacterial septic shock. In conclusion, tegumentary leishmaniasis can reactivate with simultaneous cutaneous and mucosal forms in a renal transplanted patient during the immunosuppressant therapy. Copyright © 2014 by The American Society of Tropical Medicine and Hygiene.

Cite

CITATION STYLE

APA

Tuon, F. F., Bombonatto, G. M., Battaglin, E. R., Sakumoto, M. H., Amato, V. S., Abegão De Camargo, R., & Nicodemo, A. C. (2014). Case report: Reactivation of mucosal and cutaneous leishmaniasis in a renal transplanted patient. American Journal of Tropical Medicine and Hygiene, 91(1), 81–83. https://doi.org/10.4269/ajtmh.13-0578

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free